Yue Tan

Notable publications:

Tan Y, Li J, Zhao T, et al. Clinical translation of a novel FAPI dimer [68Ga]Ga-LNC1013. Eur J Nucl Med Mol Imaging. 2024;51(2):201-209. doi:10.1007/s00259-024-06703-z. Epub ahead of print. PMID: 38561515.

Li Z, Tan Y, Li X, et al. DHRS2 inhibits cell growth and metastasis in ovarian cancer by downregulation of CHKα to disrupt choline metabolism. Cell Death Dis. 2022;13(10):845. doi:10.1038/s41419-022-05291-w. PMID: 36192391; PMCID: PMC9530226.

Quan J, Cheng C, Tan Y, et al. Acyl-CoA synthetase long-chain 3-mediated fatty acid oxidation is required for TGFβ1-induced epithelial-mesenchymal transition and metastasis of colorectal carcinoma. Int J Biol Sci. 2022;18(6):2484-2496. doi:10.7150/ijbs.69802. PMID: 35414781; PMCID: PMC8990460.

Quan J, Li N, Tan Y, et al. PGC1α-mediated fatty acid oxidation promotes TGFβ1-induced epithelial-mesenchymal transition and metastasis of nasopharyngeal carcinoma. Life Sci. 2022;300:120558. doi:10.1016/j.lfs.2022.120558. Epub 2022 Apr 19. PMID: 35452637.

Zhao X, Quan J, Tan Y, et al. RIP3 mediates TCN-induced necroptosis through activating mitochondrial metabolism and ROS production in chemotherapy-resistant cancers. Am J Cancer Res. 2021;11(3):729-745. PMID: 33791150; PMCID: PMC7994173.

Tan Y, Fang Z, Tang Y, et al. Clinical advancement of precision theranostics in prostate cancer. Front Oncol. 2023;13:1072510. doi:10.3389/fonc.2023.1072510. Published 2023 Feb 2.

Cui J, Li G, Yin J, et al. GSTP1 and cancer: Expression, methylation, polymorphisms and signaling (Review). Int J Oncol. 2020;56(4):867-878. doi:10.3892/ijo.2020.4979. Epub 2020 Feb 10. PMID: 32319549.